Kun Zhang

9PUBLICATIONS
15CO-AUTHORS
Molecular targetsClinical chemistry (incl. diagnostics)Nanoscale characterisationPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 30, 2026
Targeting AIF to trigger RIPKs/MLKL necroptosis: a disulfiram-based strategy to reverse paclitaxel resistance in ovarian cancer.

|Jun 12, 2026
Evaluation of DeepSeek-Generated Biochemistry Clinical Cases for Teaching Purpose.

|May 25, 2026
Metformin suppressed epithelial-mesenchymal transition, cisplatin resistance and metastatic potential of ovarian cancer via inhibiting TGF-β1/Smads.

|Dec 27, 2025
NAT10 triggers colorectal cancer progression via promoting PPAN-regulated DNA damage repair.

Haoran Wang, Lichen Ge, Jianing Li

|May 16, 2025
Prolyl 4-hydroxylase subunit alpha-2 acts as a TRIM21 ubiquitination substrate to promote papillary thyroid cancer progression via the glycolytic pathway.

Fengping Wu, Qian Liu, Jinkang Zhang

|Feb 16, 2024
METTL3 promotes cellular senescence of colorectal cancer via modulation of CDKN2B transcription and mRNA stability.

Zhuojia Chen, Jiawang Zhou, You Wu

Pageof 2

Frequent Collaborators

2 joint publications

Zhuojia Chen

2 joint publications

Hongsheng Wang

1 joint publications

Jiawang Zhou

1 joint publications

You Wu